Skip to main content
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data
Mutational signatures of ionizing radiation in second malignancies
Prostate Single Nucleotide Polymorphism Provides a Crucial Clue to Cancer Aggression in Active Surveillance Patients
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue
-
Our research
-
Technology platforms
-
Training and events
-
Stories and impact
